Small Molecules

26 Jul 2007 BioLineRx Initiates Phase II Trial of BL-1020, a First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia
26 Jul 2007 Kuvan Receives Priority Review Status from FDA
26 Jul 2007 Repros Reports That Patients Exposed to Proellex For Up To Six Months Demonstrated A Benign Endometrium Based On Biopsy
25 Jul 2007 ChemoCentryx Achieves $5 Million Milestone from GlaxoSmithKline for Nomination of CCR1 Small Molecule Development Candidate
25 Jul 2007 Wyeth Receives Approvable Letter from FDA for PRISTIQ for the Treatment of Vasomotor Symptoms Associated with Menopause
25 Jul 2007 FDA Oncologic Drugs Advisory Committee Recommends that FDA Wait for Overall Survival Results from Satraplatin Phase 3 Trial
25 Jul 2007 Kissei Entered into an Agreement with Nuon Therapeutics, Inc on Tranilast (Product Name: Rizaben(R))
25 Jul 2007 Aptivus(R) (tipranavir) demonstrates potent and durable treatment response in HIV-positive women
25 Jul 2007 Phase IIa Study Results Demonstrate that Once-Daily 200 mg Dosing of INCB9471 Provided Potent and Prolonged Antiviral Activity in HIV-Infected Patients
25 Jul 2007 OREXIGEN(TM) Therapeutics Reports Top-line 24 Week Results for Phase IIb Trial of EMPATIC(TM) to Treat Obesity
25 Jul 2007 Biocryst initiates Phase II clinical trial to evaluate intravenous Peramivir in patients hospitalized with influenza
25 Jul 2007 Entremed commences leukemia clinical trial for MKC-1 in Canada
25 Jul 2007 Neurochem granted fast track designation from U.S. FDA for tramiprosate (ALZHEMED(TM))
25 Jul 2007 Vicriviroc Demonstrates Potent Viral Suppression Through 48 Weeks of Therapy in ACTG Phase II Study in Treatment-Experienced HIV Patients
25 Jul 2007 Boehringer Ingelheim announces first international head-to-head trial of Aptivus(R) (tipranavir) versus darunavir in treatment-experienced HIV-positive patients
25 Jul 2007 Icagen Announces Filing of Ind for ICA-105665, a Novel Compound for the Treatment of Epilepsy
25 Jul 2007 FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk for Invasive Breast Cancer in Two Populations of Postmenopausal Women
24 Jul 2007 Advanced Magnetics Announces Positive Results from Fourth Phase III Study of Ferumoxytol as an Intravenous Iron Replacement Therapeutic in Chronic Kidney Disease Patients
24 Jul 2007 EpiCept Announces Phase III Study of EpiCept(TM) NP-1 for the Treatment of Chemotherapy Induced Peripheral Neuropathy
24 Jul 2007 Isotechnika completes patient recruitment of pivotal Phase 3 psoriasis trial
24 Jul 2007 QLT announces fda filing and review of Aczone(TM) labeling supplement for removal of blood screening requirement
24 Jul 2007 ANX-201 Combination Therapy Demonstrates Synergistic Inhibition of HIV-1 in Preclinical Tests
24 Jul 2007 BioXell starts Phase IIb European Trial of Elocalcitol in Overactive Bladder
24 Jul 2007 Akela Pharma Inc. Completes patient enrollment in its Fentanyl TAIFUN(R) Phase IIb trial
24 Jul 2007 Targacept Announces Initiation of Phase IIb Development of AZD3480 (TC-1734) for Alzheimer’s Disease

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top